Pharmaceuticals, Biotechnology and Life Sciences
STOUGHTON, Mass., April 26, 2022 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today…
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code…
Eurobio Scientific partners with Dr. Nino Guy Cassutofor the development of a new PCR test for male fertility Accelerating the…
NEW YORK, April 26, 2022 (GLOBE NEWSWIRE) — Tiziana Life Sciences Ltd (NASDAQ: TLSA) (“Tiziana” or the “Company”), a clinical-stage…
Dr. Keefe to lead the product development and manufacturing of BlueSphere Bio’s first clinical candidate, a TCR T-cell therapy directed…
Sensor Measures Oxygen Levels Within Specific Human Tissue, Potentially Allowing Biosensor Feedback of Erectile Device TherapyNEW YORK, April 26, 2022…
Montrouge, France, April 26, 2022DBV Technologies to Report First Quarter 2022 Financial Results and Recent Business Developments DBV Technologies (Euronext:…
DUBLIN, Ireland and CHICAGO, April 25, 2022 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical…
Nearly $12 million in cash and investment Fully funded for the Company’s development programs, including ketamine injection and infusion product,…
FORT COLLINS, Colo., April 22, 2022 (GLOBE NEWSWIRE) — Statera Biopharma (Nasdaq: STAB) (the “Company”), a biopharmaceutical company creating next-generation…